Astellas Pharma Inc. - Sale Or Purchase of Stock

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Sale-Or-Purchase-of-Stock" stands at -0.73 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2013.

Astellas Pharma Inc.'s first quarter result of -0.727 Billion JPY for the item "Sale Or Purchase of Stock" represents a decrease of -72,600.00 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Astellas Pharma Inc.'s first quarter result of -0.727 Billion JPY for the item "Sale Or Purchase of Stock" represents an increase of 89.55 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s first quarter result of -0.73 Billion JPY for the item "Sale Or Purchase of Stock" represents an increase of 89.51 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.23 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 6.23 Billion Japanese Yens.
The 3 year change is 59.83 Billion Japanese Yens.
The 5 year change is 53.05 Billion Japanese Yens.
The 10 year change is 48.43 Billion Japanese Yens.

The Serie's long term average value is -61.41 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 60.68 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2018, to it's latest available value, on 06/30/2025, is +180.25 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is -0.723 Billion.